Michael L. Cheng, MD
Medical OncologistDana-Farber Cancer Institute
Boston, MA
Authored Items
Faculty Perspectives: Next-Generation Sequencing Testing in Oncology | Part 4 of a 4-Part Series
The clinical application of assays that utilize next-generation sequencing (NGS) technology is accelerating rapidly in the field of oncology.
Last modified: March 9, 2021